RoscoeFMortonMDFACP, FASCO(He/Him)

Oncology • Santa Fe, NM

Gastrointestinal Cancer, Genitourinary Oncology, Hematologic Oncology

Physician

Join to view full profile

Dr. Morton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Morton's full profile

Already have an account?

Office
490A West Zia Rd. 2nd Floor
Suite 200
Santa Fe, NM 87505
Phone+1 505-913-8996

Fax+1 505-913-6445
Is this information wrong?

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1979 - 1981
University of Kansas (Wichita)Residency, Internal Medicine, 1977 - 1979
University of Kansas (Wichita)Internship, Internal Medicine, 1976 - 1977
University of Kansas School of MedicineClass of 1976, M.D., Alpha Omega Alpha
Colorado CollegeBA, Biollogy, 1968 - 1972
St. Mark's School of TexasHigh School Diploma, 1966 - 1968

Certifications & Licensure

NM State Medical License 2022 - 2026
IA State Medical License 1981 - 2025
MN State Medical License 1979 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Fellow American Society of Clinical Oncology, 2015
Fellow American College of Physicians, 1991
Member, Nominating Committee American Society of Clinical Oncology
Chair, Clinical Practice Committee American Society of Clinical Oncology, 2011-2012
Member, Government Relations Committee American Society of Clinical Oncology, 2008-2011
Member, GI Steering Committee National Cancer Insitute, 2006-2010
Member, Ethics Committee American Society of Clinical Oncology, 2003-2006
Chair, Executive Committee North Central Cancer Treatment Group, 1991-1995
Clinical Fellow American Cancer Society, 1980
Alpha Omega Alpha 1976
CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
Member NCI Task Force on Colon Cancer
Join now to see all

Clinical Trials

Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer Start of enrollment: 1998 Oct 01
Completed
Phase 3
Sorafenib in Treating Patients With Metastatic Breast Cancer Start of enrollment: 2004 Sep 01
Completed
Phase 2

Publications & Presentations

PubMed

1 citations
Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer.
Patrick McGarrah, Joleen Hubbard, Paul J Novotny, Megan E Branda, Daniel S Sargent, Roscoe F Morton, Charles S Fuchs, Al B Benson, Stephen K Williamson, Brian P Findla...> ;Cancer Control. 2023 Jun 20
14 citations
Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404).
Alan L Ho, Nathan R Foster, Alex J Zoroufy, Jordan D Campbell, Francis Worden, Katharine Price, Douglas Adkins, Daniel W Bowles, Hyunseok Kang, Barbara Burtness, Eric ...> ;Journal of Clinical Oncology. 2022 Dec 20
15 citations
A Pathway Through the Bundle Jungle.
Blase N. Polite, Jeffery C. Ward, John Cox, Roscoe F. Morton, John W. Hennessy, Ray D. Page, Rena M. Conti> ;Journal of Oncology Practice. 2016 May 12
6 citations
Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs plac...
Terence T. Sio, Pamela J. Atherton, Brandon Birckhead, David Schwartz, Jeff A. Sloan, Drew K. Seisler, James A. Martenson, Charles L. Loprinzi, Patricia C. Griffin, Ro...> ;Supportive Care in Cancer. 2016 Apr 14
Reply to M. Thompson et al
Blase N. Polite, Jeffery C. Ward, John Cox, Roscoe F. Morton, John E. Hennessy, Ray D. Page, Rena M. Conti> ;Journal of Oncology Practice. 2015 Mar 3
19 citations
Payment for oncolytics in the United States: a history of buy and bill and proposals for reform.
Blase N. Polite, Jeffery C. Ward, John Cox, Roscoe F. Morton, John W. Hennessy, Ray D. Page, Rena M. Conti> ;Journal of Oncology Practice. 2014 Nov 1
13 citations
The Upper Midwest Health Study: gliomas and occupational exposure to chlorinated solvents
Avima M. Ruder, James H. Yiin, Martha A. Waters, Tania Carreón, Misty J. Hein, Mary Ann Butler, Geoffrey M. Calvert, Karen E Davis-King, Paul A. Schulte, Jack S. Mande...> ;Occupational and Environmental Medicine. 2013 Feb 1
8 citations
The Upper Midwest Health Study: industry and occupation of glioma cases and controls.
Avima M. Ruder, Martha A. Waters, Tania Carreón, Mary Ann Butler, Geoffrey M. Calvert, Karen E Davis-King, Kathleen M. Waters, Paul A. Schulte, Jack S. Mandel, Roscoe ...> ;American Journal of Industrial Medicine. 2012 Sep 1
12 citations
The upper midwest health study: a case–control study of pesticide applicators and risk of glioma
James H. Yiin, Avima M. Ruder, Patricia A. Stewart, Martha A. Waters, Tania Carreón, Mary Ann Butler, Geoffrey M. Calvert, Karen E Davis-King, Paul A. Schulte, Jack S....> ;Environmental Health. 2012 Jun 12
13 citations
CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma.
Nadia N. Laack, Brian P. O'Neill, Karla V. Ballman, Judith R. O'Fallon, Xiomara W. Carrero, Paul J. Kurtin, Bernd W. Scheithauer, Paul D. Brown, Thomas M. Habermann, J...> ;International Journal of Radiation Oncology, Biology, Physics. 2011 Oct 1
164 citations
Pharmacogenetic Predictors of Adverse Events and Response to Chemotherapy in Metastatic Colorectal Cancer: Results From North American Gastrointestinal Intergroup Tria...
Howard L. McLeod, Daniel J. Sargent, Sharon Marsh, Erin M. Green, Cristi R. King, Charles S. Fuchs, Ramesh K. Ramanathan, Stephen K. Williamson, B. Findlay, Stephen N....> ;Journal of Clinical Oncology. 2010 Jul 10
5 citations
Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM.
Kurt A. Jaeckle, Karla V. Ballman, Caterina Giannini, Paula J. Schomberg, Matthew M. Ames, Joel M. Reid, Renee M. McGovern, Stephanie L. Safgren, Evanthia Galanis, Joo...> ;Journal of Neuro-Oncology. 2010 Jan 9
9 citations
NCCTG Study N9741: Leveraging Learning from an NCI Cooperative Group Phase III Trial
Richard M. Goldberg, Daniel J. Sargent, Roscoe F. Morton, Erin H. Green, Hanna K. Sanoff, Howard L. McLeod, Jan C. Buckner> ;The Oncologist. 2009 Oct 1
43 citations
Exposure to Farm Crops, Livestock, and Farm Tasks and Risk of Glioma The Upper Midwest Health Study
Avima M. Ruder, Tania Carreón, Mary Ann Butler, Geoffrey M. Calvert, Karen E Davis-King, Martha A. Waters, Paul A. Schulte, Jack S. Mandel, Roscoe F. Morton, Douglas J...> ;American Journal of Epidemiology. 2009 Jun 15
A phase II trial of carboplatin (C) and nab-paclitaxel (ABI-007-nab-P) in patients with unresectable stage IV melanoma: Final data from N057E.
Markovic SN, Suman VJ, Kottschade LA, Amatruda T, McWilliams RR, Dakhil SR, Nikcevich DA, Morton RF, Fitch TR, Jaslowski AJ> ;J. Clin. Oncol.. 2009-05-20
925 citations
American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Respons...
Carmen J. Allegra, J. Milburn Jessup, Mark R. Somerfield, Stanley R. Hamilton, Elizabeth H. Hammond, Daniel F. Hayes, Pamela K. McAllister, Roscoe F. Morton, Richard L...> ;Journal of Clinical Oncology. 2009 Apr 20
19 citations
ASCO Provisional Clinical Opinion: KRAS, Cetuximab, and Panitumumab—Clinical Implications in Colorectal Cancer
Roscoe F. Morton, Elizabeth H. Hammond> ;Journal of Oncology Practice. 2009 Mar 1
94 citations
Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study...
Domingo G. Perez, Vera J. Suman, Tom R. Fitch, Thomas Amatruda, Roscoe F. Morton, Shamim Z. Jilani, Costas L. Constantinou, James R. Egner, Lisa A. Kottschade, Svetomi...> ;Cancer. 2009 Jan 1
125 citations
Phase II Trial of Sorafenib in Patients With Metastatic Breast Cancer Previously Exposed to Anthracyclines or Taxanes: North Central Cancer Treatment Group and Mayo Cl...
Alvaro Moreno-Aspitia, Roscoe F. Morton, David W. Hillman, Wiltna L. Lingle, Kendrith M. Rowland, Martin Wiesenfeld, Patrick J. Flynn, Tom R. Fitch, Edith A. Perez> ;Journal of Clinical Oncology. 2009 Jan 1
228 citations
Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741
Hanna K. Sanoff, Daniel J. Sargent, Megan E. Campbell, Roscoe F. Morton, Charles S. Fuchs, Ramesh K. Ramanathan, Stephen K. Williamson, B. Findlay, Henry C. Pitot, Ric...> ;Journal of Clinical Oncology. 2008 Dec 10
18 citations
A dose-escalation study of aerosolized sargramostim in the treatment of metastatic melanoma: an NCCTG Study.
Svetomir N. Markovic, Vera J. Suman, Wendy K. Nevala, Louis Geeraerts, Edward T. Creagan, Lori A. Erickson, Kendrith M. Rowland, Roscoe F. Morton, William L. Horvath, ...> ;American Journal of Clinical Oncology. 2008 Dec 1
206 citations
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group...
Paul D. Brown, Sunil Krishnan, J. N. Sarkaria, Wenting Wu, Kurt A. Jaeckle, Joon H. Uhm, Francois J. Geoffroy, Robert M. Arusell, Gaspar J. Kitange, Robert B. Jenkins,...> ;Journal of Clinical Oncology. 2008 Dec 1
175 citations
Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group.
Stephen M. Ansell, David J. Inwards, Kendrith M. Rowland, Patrick J. Flynn, Roscoe F. Morton, Dennis F. Moore, Scott H. Kaufmann, Irene M. Ghobrial, Paul J. Kurtin, Ma...> ;Cancer. 2008 Aug 1
57 citations
Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central C...
David J. Inwards, Paul A. S. Fishkin, David W. Hillman, David W. Brown, Stephen M. Ansell, Paul J. Kurtin, Rafael Fonseca, Roscoe F. Morton, Michael H. Veeder, Thomas ...> ;Cancer. 2008 Jul 1
A phase II trial of carboplatin and ABI-007 in patients with unresectable stage IV melanoma, N057E.
Kottschade LA, Suman VJ, Amatruda T, McWilliams RR, Dakhil SR, Nikcevich DA, Morton RF, Fitch TR, Jaslowski AJ, Markovic SN> ;J. Clin. Oncol.. 2008-05-20
Join now to see all